American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
- 20 April 2014
- journal article
- editorial material
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (12), 1277-1280
- https://doi.org/10.1200/jco.2013.53.8009
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Cancer Genome LandscapesScience, 2013
- Trastuzumab Emtansine for HER2-Positive Advanced Breast CancerThe New England Journal of Medicine, 2012
- Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus SyndromeThe New England Journal of Medicine, 2012
- The American Society of Clinical Oncology's Blueprint for Transforming Clinical and Translational Cancer ResearchJournal of Clinical Oncology, 2012
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationThe New England Journal of Medicine, 2011
- Analysis of the Yield of Phase II Combination Therapy Trials in Medical OncologyClinical Cancer Research, 2010
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerThe New England Journal of Medicine, 2010
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaThe New England Journal of Medicine, 2010
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaThe New England Journal of Medicine, 2010
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell CarcinomaThe New England Journal of Medicine, 2009